Searchable abstracts of presentations at key conferences in endocrinology

ea0065p154 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Checkpoint inhibitors and immune related diabetes mellitus: a case series

Hanafy Ahmed , Seejore Khyatisha , Kyriakakis Nikolaos , Al-Qaissi Ahmed , Kassim Saifuddin , Marples Maria , Murray Robert D

Introduction: Checkpoint inhibitors (CPi) are finding a place in the treatment algorithm of an increasing number of cancers. Immune-related (ir) endocrinopathies are frequent side-effects. Diabetes mellitus (irDM) is infrequent, but often presents acutely and can be potentially life-threatening There are ˜60–70 cases characterising irDM in the literature. We describe 4 cases of irDM to add to the understanding of this condition. All four patients were undergoing trea...

ea0063p416 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

High prevalence of autonomous aldosterone secretion in patients with type 2 Diabetes Mellitus and arterial hypertension. The effect of SGLT2 inhibitors on renin-angiotensin-aldosterone system

Tyfoxylou Ernestini , Papanastasiou Labrini , Piaditis George , Voulgaris Nikolaos , Chrousos George , Kounadi Theodora

Introduction: The causes of arterial hypertension in diabetic and non-diabetic hypertensive patients are still not clear. However, in recent studies in non-diabetic hypertensive patients (NDHP) we observed dysregulation of aldosterone (ALD) secretion either in the form of autonomous secretion or as hyperesponse to stress. To the best of our knowledge, a similar study in hypertensive patients with type 2 Diabetes Mellitus (DHP) has not been conducted yet....

ea0063p718 | Pituitary and Neuroendocrinology 2 | ECE2019

A rare case of a TSH/GH secreting pituitary macroadenoma

Gogakos Apostolos , Efstathiadou Zoe , Tsirou Efrosini , Lypiridou Sofia , Mintziori Gesthimani , Kostopoulos Ioannis , Foroglou Nikolaos , Kita Marina

Introduction: Thyrotropin (TSH) secreting pituitary adenomas (TSHomas) are very rare and account for less than 2% of all pituitary adenomas. They present with elevated levels of fT4 and normal to high levels of TSH. About 25% of TSHomas co-secrete other anterior pituitary hormones. Growth hormone (GH) is the most commonly co-secreted hormone, followed by prolactin (PRL) and gonadotropins. Herein, we report a case of pituitary adenoma with simultaneous secretion of TSH and GH.<...

ea0063p1172 | Thyroid 3 | ECE2019

Graves’ disease associated with severe pancytopenia; case report

Terzaki Alexandra , Varveris Evangelos , Merkoviti Maria , Christou Maria , Siolos Athanasios , Chaliasos Nikolaos , Makis Alexandros , Tigas Stelios

Introduction: Thyrotoxicosis may be associated with anemia (10–34% of thyrotoxic patients), leucopenia (15–30%) and thrombocytopenia (2–5%). We present the case of a 13-year-old girl with Graves’ disease associated with severe pancytopenia.Case presentation: The patient presented with menorrahgia and symptoms suggestive of an upper respiratory tract infection. On examination she was afebrile with a pulse rate of 100/min at rest. She h...

ea0049ep1378 | Thyroid (non-cancer) | ECE2017

Thyroid autoimmunity and risk of incidental thyroid microcarcinoma in non-toxic nodular thyroid diseases

Askitis Dimitrios , Efremidou Eleni I , Karanikas Michail A , Tripsianis Grigorios , Giatromanolaki Alexandra , Polychronidis Alexandros , Lyratzopoulos Nikolaos

Aim: Thyroid cancer comprises the most common endocrine malignancy and a variety of studies have investigated the role of thyroid autoimmunity as an independent risk factor for the manifestation of differentiated thyroid cancer in otherwise benign thyroid disorders. Objective of the current retrospective study is the assessment of any possible correlation between thyroid autoimmunity, in terms of elevated thyroid autoantibodies, and incidental thyroid microcarcinoma (ITC) in n...

ea0044p133 | Neoplasia, cancer and late effects | SFEBES2016

Adverse fibrin network profile in survivors of brain tumours with established hormonal deficiencies: A potential mechanism for increased vascular risk

Kyriakakis Nikolaos , Kumar Satish S , Oxley Natalie , Phoenix Fladia , Lynch Julie , Ajjan Ramzi , Murray Robert D

Introduction: Long-term survivors of childhood-onset brain tumours have increased risk of premature vascular disease by mechanisms that remain unclear. We hypothesised that a thrombotic fibrin network profile is one mechanism for the increased vascular risk in this population.Methods: We undertook a cross-sectional study in 33 patients with previous history of brain tumours and 33 age and sex-matched healthy controls. We performed clot structure analysis...

ea0044p251 | Thyroid | SFEBES2016

Distribution of free T4 levels in patients with low-risk thyroid cancer on thyroid hormone replacement and pituitary diseases: comparison with the normal population

Seejore Khyatisha , Kyriakakis Nikolaos , Gerrard Georgina , Gill Vanessa , Murray Robert D

Background: Diagnosing secondary hypothyroidism can be challenging, particularly for patients with low-normal free T4 (fT4). Thyroid hormone replacement (THR) in these cases is guided by the normal population fT4 range. The aim of this study was to compare thyroid function tests in thyroid cancer patients on THR and patients with pituitary diseases with or without central hypothyroidism.Methods: We retrospectively collect...

ea0041ep419 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Association between 25-hydroxyvitamin D levels and diabetes

Papadakis Georgios , Kakava Kassiani , Pappa Theodora , Dogkas Nikolaos , Villiotou Vassiliki , Pappas Anastasios

Introduction: A significant body of literature supports that 25(OH)vitD deficiency is associated with insulin resistance. We studied the prevalence of 25(OH)vitD deficiency across the spectrum of glucose metabolism.Design: The study participants (441 total, 362 females (82.1%) and 79 males (17.9%)) had a mean age (±S.D.) of 64.59 (±9.44) years, range: 32–92 years. The study population was divided into two groups: Individuals...

ea0041ep651 | Endocrine tumours and neoplasia | ECE2016

Hirsutism with rapid onset presenting in a 62-year-old postmenopausal woman

Tzaves Ioannis , Papadakis Georgios , Moustakas Konstantinos , Keramidas Ioannis , Kaltzidou Victoria , Veniou Eirini , Kalinoglou Nikolaos , Tertipi Athanasia

Introduction: Virilizing tumors are rare, but frequent cause of virilization in postmenopausal women.Case report: A 62-year-old postmenopausal woman presented with a rapid onset of hirsutism with increased terminal hair growth, particular on chin and abdomen, frontal male pattern balding in the last 5 months. Physical examination revealed a low-pitched, deepened voice and clitoromegaly. The Ferriman–Gallwey score was 18. Laboratory evaluation: Testo...

ea0041ep785 | Obesity | ECE2016

Interventional changes of thyroid hormone levels do not affect circulating irisin levels in humans

Panagiotou Grigorios , Pazaitou-Panayiotou Kalliopi , Komninou Despina , Paschou Stavroula A. , Kalogeris Nikolaos , Vryonidou Andromachi , Mantzoros Christos S.

Introduction: Thyroid hormones and irisin increase energy expenditure and induce browning of adipose tissue. However, little is known about irisin physiology and regulation. Here we aim to elucidate whether thyroid hormones alter circulating irisin concentrations in humans.Design and subjects: One cross-sectional (case-control) evaluation and two interventions were performed independently from each other, including previously thyroidectomized patients. C...